Literature DB >> 29019451

Autoimmunity in a cohort of 471 patients with primary antibody deficiencies.

Gholamreza Azizi1,2,3,4, Marzieh Tavakol1,5, Hosein Rafiemanesh6,7, Fatemeh Kiaee3, Reza Yazdani3, Amin Heydari3, Kosar Abouhamzeh3, Pardis Anvari3, Sara Mohammadikhajehdehi3, Laleh Sharifia3, Yasser Bagheri8,9, Hamed Mohammadi10, Hassan Abolhassani3,4,11, Asghar Aghamohammadi3,4.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the frequency of autoimmunity in primary antibody deficiency (PAD).
METHODS: A total of 471 patients with PADs enrolled in this retrospective cohort study. For all patients' demographic information, clinical records and laboratory data were collected to investigate autoimmune complications.
RESULTS: Autoimmune disorders as the first presentation of immunodeficiency were recorded in 11 patients (2.5%). History of autoimmunity was recorded in 125 patients during the course of the disease (26.5%). The frequency of autoimmunity in common variable immune deficiency (32.0%) was higher than other forms of PADs. The most common autoimmune manifestations were reported to be autoimmune gastrointestinal disease and autoimmune cytopenias. Among patients with autoimmunity, 87 patients (69.6%) had a history of one autoimmune disorder, while 38 patients (30.4%) had a history of multiple autoimmunities. The immune thrombocytopenic purpura and autoimmune hemolytic anemia were the most two concomitant autoimmune disorders in 16 (42.1%) of 38 patients with multiple autoimmunities. Comparing the frequency of Tregs in PAD patients with autoimmunity showed that, patients with multiple autoimmunities had lower Tregs than those with single autoimmunity (p = 0.017).
CONCLUSION: It is important that non-immunologist physicians be alert of the associated autoimmunity with PADs in order to reduce the diagnostic delay and establish timely immunoglobulin replacement therapy in these patients.

Entities:  

Keywords:  Primary antibody deficiencies; autoimmune hemolytic anemia; autoimmunity; immune thrombocytopenic purpura

Mesh:

Substances:

Year:  2017        PMID: 29019451     DOI: 10.1080/1744666X.2017.1384312

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  7 in total

1.  Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center.

Authors:  Jinhong Wu; Wenwei Zhong; Yong Yin; Hao Zhang
Journal:  BMC Pediatr       Date:  2019-11-04       Impact factor: 2.125

Review 2.  Arthritis in children with LRBA deficiency - case report and literature review.

Authors:  Rotem Semo Oz; Melissa S Tesher
Journal:  Pediatr Rheumatol Online J       Date:  2019-12-17       Impact factor: 3.054

Review 3.  Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults.

Authors:  Ida Judyta Malesza; Michał Malesza; Iwona Krela-Kaźmierczak; Aleksandra Zielińska; Eliana B Souto; Agnieszka Dobrowolska; Piotr Eder
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

4.  Common variable immunodeficiency: different faces of the same disease.

Authors:  Elżbieta Grześk; Anna Dąbrowska; Anna Urbañczyk; Marlena Ewertowska; Mariusz Wysocki; Sylwia Kołtan
Journal:  Postepy Dermatol Alergol       Date:  2021-11-05       Impact factor: 1.837

Review 5.  The Role of HLA in the Association between IgA Deficiency and Celiac Disease.

Authors:  Dimitri Poddighe; Cristina Capittini
Journal:  Dis Markers       Date:  2021-12-13       Impact factor: 3.434

6.  Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19.

Authors:  Hassan Abolhassani; Samaneh Delavari; Nils Landegren; Sima Shokri; Paul Bastard; Likun Du; Fanglei Zuo; Reza Hajebi; Farhad Abolnezhadian; Sara Iranparast; Mohammadreza Modaresi; Ahmad Vosughimotlagh; Fereshte Salami; Maribel Aranda-Guillén; Aurélie Cobat; Harold Marcotte; Shen-Ying Zhang; Qian Zhang; Nima Rezaei; Jean-Laurent Casanova; Olle Kämpe; Lennart Hammarström; Qiang Pan-Hammarström
Journal:  J Allergy Clin Immunol       Date:  2022-09-13       Impact factor: 14.290

7.  Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency.

Authors:  Pasquale Comberiati; Giorgio Costagliola; Niccolò Carli; Annalisa Legitimo; Sofia D'Elios; Rita Consolini; Diego G Peroni
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.